Home
About
Overview
Sharing Data
ORCID
Help
History (1)
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. J Transl Med. 2009 May 20; 7:35.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antigens, CD
Autoimmunity
CTLA-4 Antigen
Enzyme-Linked Immunosorbent Assay
Female
Humans
Interleukin-17
Intracellular Space
Lymphocyte Activation
Male
Melanoma
Middle Aged
Neoplasm Metastasis
T-Lymphocytes, Helper-Inducer
authors with profiles
Thinle Chodon
Richard Koya